蔣凡

【摘要】目的:分析研究急診科心肌梗塞臨床救治方法和效果,總結(jié)相關(guān)經(jīng)驗(yàn)。方法:選取2013年2月至2014年2月本院94例心肌梗塞患者作為研究對象,依據(jù)抽簽法隨機(jī)抽取觀察組(n=47)和對照組(n=47),給予對照組患者靜脈溶栓救治,給予對照組患者常規(guī)救治措施,比對兩組患者救治效果。結(jié)果:觀察組血管再通率44.6%明顯高于于對照的23.4%,差異具有統(tǒng)計(jì)學(xué)意義(X2=4.738,P<0.05);觀察組病死率8.5%低于對照組44.6%,差異具有統(tǒng)計(jì)學(xué)意義(X2=15.7484,P<0.05)。結(jié)論:通過使用靜脈溶栓對心肌梗塞患者進(jìn)行治療,能有效促進(jìn)血管再通,降低病死率,治療效果顯著,具有臨床用藥意義。
【關(guān)鍵詞】心肌梗塞;救治;靜脈溶栓
[Abstract] Objective: To analyze the clinical treatment method and effect of acute myocardial infarction in emergency department, and to sum up the relevant experience. Methods: Selected 94 cases of patients with myocardial infarction in our hospital from Feb 2013 to Feb 2014, they will divided into observation group (n = 47) and control group (n = 47), the observation group received intravenous thrombolytic treatment, while control group received routine treatment, and then compared the curative effect of two groups. Results: The vascular recanalization rate of observation group of was 44.6%, which was significantly higher than 23.4% of control group, and the difference has statistical significance (X2=4.738, P < 0.05). The mortality rate of observation group was 8.5%, which was lower than 44.6% of the control group, and the difference has statistical significance (X2=15.7484, P < 0.05). Conclusion: The treatment of myocardial infarction by using intravenous thrombolysis can promote the revascularization reduce the mortality effectively. The treatment effect is remarkable and has clinical significance.
Keywords: myocardial infarction; treatment; intravenous thrombolysis
【中圖分類號】R4 【文獻(xiàn)標(biāo)識碼】B 【文章編號】1671-8801(2015)04-0048-02
心肌梗塞主要是由于冠狀動脈閉塞,血流出現(xiàn)中斷,導(dǎo)致部分心肌因?yàn)閲?yán)重持久性的缺血而引發(fā)的局部壞死【1】。臨床表現(xiàn)為心肌損傷、缺血、血紅細(xì)胞沉降率加快等一系列癥狀。通過相關(guān)研究表明,在急診中使用靜脈溶栓對患者進(jìn)行治療,已成為救治心肌梗塞患者的重要舉措。本文通過回顧性分析本院94例心肌梗塞臨床救治方法和效果,作如下報(bào)告:
1.資料與方法
1.1一般資料
選取本院2013年2月至2014年2月94例心肌梗塞患者作為研究對象。根據(jù)抽簽法分組方法將其分為觀察組(n=47)和對照組(n=47),觀察組男27例,女20例,年齡在42~81歲,平均年齡(56.3±3.7)歲;從發(fā)病期到入院時(shí)間為5~13h。對照組男26例,女21例,年齡在45~83歲,平均年齡(57.5±4.6)歲;從發(fā)病期到入院時(shí)間為5~12h。兩組患者性別、年齡、病情等方面比較差異無統(tǒng)計(jì)學(xué)意義(P>0.05),具有可比性。所有患者在知悉本次研究目的后,均同意參與實(shí)驗(yàn),并簽署知情同意書。
1.2方法
①觀察組:予以靜脈溶栓進(jìn)行救治,將150萬尿激酶(國藥準(zhǔn)字H22023016,吉林省輝南長龍生化藥業(yè)股份……